Dr. Susan Rosencrance serves as the Deputy Director for Science in CDER’s Office of Pharmaceutical Quality (OPQ). She is performing this role in addition to serving as the Director for the Office of Product Quality III, also within OPQ.
She has spent more than 25 years at the FDA serving in a variety of senior roles including the Acting Director for CDER’s Office of Generic Drugs in 2022-2023, Director for the Office of Lifecycle Drug Products in OPQ from 2015-2022, as well as the Deputy Director for Generic Drug Chemistry from 2013-2015 in CDER’s former Office of Pharmaceutical Science.
Before joining the FDA, Susan worked in a drug discovery program at Merck in Rahway, New Jersey. She holds a B.S. in Biochemistry and a Ph.D. in Chemistry and completed her dissertation research in protein modeling at the NIH Laboratory for Biophysical Chemistry
